Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine.
暂无分享,去创建一个
[1] M. Blüher,et al. Molecular characteristics of serum visfatin and differential detection by immunoassays. , 2007, The Journal of clinical endocrinology and metabolism.
[2] N. Kohno,et al. Circulating visfatin level is correlated with inflammation, but not with insulin resistance , 2007, Clinical endocrinology.
[3] R. Nazar,et al. Borrowing from Biology , 2007, Science.
[4] D. Grattan,et al. Fasting-induced adipose factor identified as a key adipokine that is up-regulated in white adipose tissue during pregnancy and lactation in the rat. , 2007, The Journal of endocrinology.
[5] E. Tsai,et al. Increased plasma visfatin concentrations in women with polycystic ovary syndrome. , 2007, Fertility and sterility.
[6] M. Matsuda,et al. Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway. , 2007, Biochemical and biophysical research communications.
[7] Daniel P Morse,et al. Direct selection of RNA beacon aptamers. , 2007, Biochemical and biophysical research communications.
[8] M. Rauh,et al. Preanalytical influences on the measurement of visfatin by enzyme immuno assay. , 2007, Clinica chimica acta; international journal of clinical chemistry.
[9] K. Cianflone,et al. Visfatin expression is hormonally regulated by metabolic and sex hormones in 3T3‐L1 pre‐adipocytes and adipocytes , 2007, Diabetes, obesity & metabolism.
[10] H. J. Yoo,et al. Effect of PPAR-δ agonist on the expression of visfatin, adiponectin, and resistin in rat adipose tissue and 3T3-L1 adipocytes , 2007 .
[11] S. Cregan,et al. Extension of Human Cell Lifespan by Nicotinamide Phosphoribosyltransferase* , 2007, Journal of Biological Chemistry.
[12] H. Randeva,et al. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance , 2007, Diabetologia.
[13] M. Fasshauer,et al. Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function , 2007, Clinical endocrinology.
[14] S. Tonstad,et al. Increased Expression of Visfatin in Macrophages of Human Unstable Carotid and Coronary Atherosclerosis: Possible Role in Inflammation and Plaque Destabilization , 2007, Circulation.
[15] J. Carrero,et al. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] W. Ricart,et al. Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. , 2007, The Journal of clinical endocrinology and metabolism.
[17] Bounleut Phanavanh,et al. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. , 2007, The Journal of clinical endocrinology and metabolism.
[18] H. Tilg,et al. Visfatin , an Adipocytokine with Proinflammatory and Immunomodulating Properties 1 , 2007 .
[19] W. Qian. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance , 2007 .
[20] B. Pedersen,et al. Visfatin mRNA expression in human subcutaneous adipose tissue is regulated by exercise. , 2007, American journal of physiology. Endocrinology and metabolism.
[21] Joe G. N. Garcia,et al. Genomic insights into acute inflammatory lung injury. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[22] H. Randeva,et al. Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin. , 2006, The Journal of clinical endocrinology and metabolism.
[23] G. Schernthaner,et al. Increase in Visfatin after Weight Loss Induced by Gastroplastic Surgery , 2006, Obesity.
[24] M. Wolzt,et al. Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes. , 2006, The Journal of clinical endocrinology and metabolism.
[25] M. Wolzt,et al. Free fatty acids normalize a rosiglitazone-induced visfatin release. , 2006, American journal of physiology. Endocrinology and metabolism.
[26] M. Matsuda,et al. Visfatin in adipocytes is upregulated by hypoxia through HIF1alpha-dependent mechanism. , 2006, Biochemical and biophysical research communications.
[27] K. Cianflone,et al. Effects of fatty acid regulation on visfatin gene expression in adipocytes. , 2006, Chinese medical journal.
[28] M. Wolzt,et al. The Adipokine Visfatin is Markedly Elevated in Obese Children , 2006, Journal of pediatric gastroenterology and nutrition.
[29] J. Fernández-Real,et al. Serum Visfatin Increases With Progressive β-Cell Deterioration , 2006, Diabetes.
[30] S. Eom,et al. Crystal structure of visfatin/pre-B cell colony-enhancing factor 1/nicotinamide phosphoribosyltransferase, free and in complex with the anti-cancer agent FK-866. , 2006, Journal of molecular biology.
[31] T. Forst,et al. Comment on: Haider DG, Schaller G, Kapiotis S, Maier C, Luger A, Wolzt M (2006) The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 49:1909–1914 , 2006, Diabetologia.
[32] R. Vettor,et al. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. , 2006, The Journal of clinical endocrinology and metabolism.
[33] M. Yoo,et al. Hypoxic induction of human visfatin gene is directly mediated by hypoxia‐inducible factor‐1 , 2006, FEBS letters.
[34] C. Fielding,et al. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. , 2006, Arthritis and rheumatism.
[35] E. Tsai,et al. Decreased Plsma Visfatin Concentrations in Women With Gestational Diabetes Mellitus , 2006, The Journal of the Society for Gynecologic Investigation: JSGI.
[36] C. Wolberger,et al. Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme , 2006, Nature Structural &Molecular Biology.
[37] G. Schernthaner,et al. Increased visfatin concentrations in women with gestational diabetes mellitus. , 2006, Clinical science.
[38] M. Wolzt,et al. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. , 2006, The Journal of clinical endocrinology and metabolism.
[39] M. Laakso,et al. Visfatin is an adipokine, but it is not regulated by thiazolidinediones. , 2006, The Journal of clinical endocrinology and metabolism.
[40] R. Busse,et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin , 2006, Diabetologia.
[41] J. Gómez-Reino,et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis , 2006, Annals of the rheumatic diseases.
[42] Shyi-Jang Shin,et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. , 2006, The Journal of clinical endocrinology and metabolism.
[43] Yohei Hayashi,et al. Rhythmic messenger ribonucleic acid expression of clock genes and adipocytokines in mouse visceral adipose tissue. , 2005, Endocrinology.
[44] S. Ye,et al. Pre-B-cell-colony-enhancing factor is critically involved in thrombin-induced lung endothelial cell barrier dysregulation. , 2005, Microvascular research.
[45] K. Choi,et al. Effect of PPAR-α and -γ agonist on the expression of visfatin, adiponectin, and TNF-α in visceral fat of OLETF rats☆ , 2005 .
[46] M. Fasshauer,et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. , 2005, Diabetes.
[47] R. Paschke,et al. Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. , 2005, American journal of physiology. Endocrinology and metabolism.
[48] M. Matsuda,et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. , 2005, Science.
[49] Reinhard Guthke,et al. Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. , 2005, European journal of dermatology : EJD.
[50] N. Klöting,et al. Visfatin: gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats. , 2005, Biochemical and biophysical research communications.
[51] J. Pickering,et al. Pre–B-Cell Colony–Enhancing Factor Regulates NAD+-Dependent Protein Deacetylase Activity and Promotes Vascular Smooth Muscle Cell Maturation , 2005, Circulation research.
[52] R. Paschke,et al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. , 2005, The Journal of endocrinology.
[53] S. Imai,et al. The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells* , 2004, Journal of Biological Chemistry.
[54] J. Marshall,et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. , 2004, The Journal of clinical investigation.
[55] J. Capeau,et al. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. , 2003, Biochemical and biophysical research communications.
[56] H. Fujisawa,et al. Growth phase‐dependent changes in the subcellular localization of pre‐B‐cell colony‐enhancing factor 1 , 2003, FEBS letters.
[57] D. Gigot,et al. Pre‐B‐cell colony‐enhancing factor, whose expression is up‐regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis , 2002, European journal of immunology.
[58] S. Ognjanovic,et al. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. , 2001, Journal of molecular endocrinology.
[59] J. Després,et al. Obesity and Insulin Resistance , 1999 .
[60] B. Spiegelman,et al. Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling. , 1997, The Journal of clinical investigation.
[61] S. Snyder,et al. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. , 1994, Science.
[62] I McNiece,et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor , 1994, Molecular and cellular biology.